Keeping Your Company’s Federal Contracting Options Safe in the Face of Pending BIOSECURE Act Legislation
FDA Law Blog
MARCH 3, 2024
Background Section 2 of the House Bill outlines some of the historical background that spurred Congressional action here, including national security risks highlighted by U.S. Office of Management and Budget (OMB) can also specify other equipment or services to be subject to the Act’s prohibitions.
Let's personalize your content